ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Massachusetts » Internal Medicine

Top Internal Medicine Prescribers in Massachusetts

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
MILTON REDER M.D.

Internal Medicine

0

$0

0
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

0%
prescriptions for brand name drugs

Avg: 22%

$0
Average prescription price

Avg: $56

MICHELLE MORREALE-KARL MD

Internal Medicine

0

$0

0
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

0%
prescriptions for brand name drugs

Avg: 22%

$0
Average prescription price

Avg: $56

SURINDERPAL SIDHU MD

Internal Medicine

0

$0

0
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

0%
prescriptions for brand name drugs

Avg: 22%

$0
Average prescription price

Avg: $56

NAMEETA DOOKERAN MD

Internal Medicine

84

$11.2K

13
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

100%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

94%
prescriptions for brand name drugs

Avg: 22%

$134
Average prescription price

Avg: $56

ANTHONY SCHLAFF MD

Internal Medicine

86

$32.2K

14
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

93%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

74%
prescriptions for brand name drugs

Avg: 22%

$374
Average prescription price

Avg: $56

ANTHONY KUSIAK M.D.

Internal Medicine

86

$369

33
0 are 65+

70%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

0%
prescriptions for brand name drugs

Avg: 22%

$4
Average prescription price

Avg: $56

NICHOLAS RENCRICCA M.D.

Internal Medicine

88

$15.1K

18
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

78%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

85%
prescriptions for brand name drugs

Avg: 22%

$172
Average prescription price

Avg: $56

STEVEN FINE MD

Internal Medicine

90

$10.1K

67
63 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

77%
prescriptions for brand name drugs

Avg: 22%

$113
Average prescription price

Avg: $56

GERBURG WULF M.D.

Internal Medicine

115

$19.5K

30
26 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

13%
prescriptions for brand name drugs

Avg: 22%

$170
Average prescription price

Avg: $56

CHRISTOPHER KEROACK MD

Internal Medicine

125

$1,577

25
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

0%
prescriptions for brand name drugs

Avg: 22%

$13
Average prescription price

Avg: $56

ABA EWUSI

Internal Medicine

139

$10.4K

66
39 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

30%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

60%
prescriptions for brand name drugs

Avg: 22%

$75
Average prescription price

Avg: $56

JOHN NADAI MD

Internal Medicine

154

$8,504

33
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

8%
prescriptions for brand name drugs

Avg: 22%

$55
Average prescription price

Avg: $56

WILLIAM STRAUB M.D.

Internal Medicine

198

$42.3K

21
0 are 65+

57%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

65%
prescriptions for brand name drugs

Avg: 22%

$214
Average prescription price

Avg: $56

PATRICK GORDAN MD

Internal Medicine

228

$41.5K

42
37 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

71%
prescriptions for brand name drugs

Avg: 22%

$182
Average prescription price

Avg: $56

SUSAN ABEND M.D.

Internal Medicine

239

$24.2K

45
36 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

48%
prescriptions for brand name drugs

Avg: 22%

$101
Average prescription price

Avg: $56

JASON DETTORI M.D.

Internal Medicine

244

$3,440

88
72 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

39%
prescriptions for brand name drugs

Avg: 22%

$14
Average prescription price

Avg: $56

AMANDA POWELL MD

Internal Medicine

266

$20.1K

53
11 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 22%

$76
Average prescription price

Avg: $56

ERIN DEROSE M.D.

Internal Medicine

268

$173K

43
38 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 22%

$645
Average prescription price

Avg: $56

SARA SHADCHEHR D.O.

Internal Medicine

268

$54K

92
76 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

75%
prescriptions for brand name drugs

Avg: 22%

$202
Average prescription price

Avg: $56

TINA RIZACK M.D., M.P.H.

Internal Medicine

282

$23.7K

63
46 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

11%
prescriptions for brand name drugs

Avg: 22%

$84
Average prescription price

Avg: $56

GERALDINE FINLAY M.D.

Internal Medicine

294

$59.2K

39
29 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

61%
prescriptions for brand name drugs

Avg: 22%

$201
Average prescription price

Avg: $56

JACQUELINE CHU MD

Internal Medicine

295

$17.8K

31
20 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 22%

$60
Average prescription price

Avg: $56

SHAMSAH KAZANI M.D.

Internal Medicine

303

$60.7K

50
34 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

78%
prescriptions for brand name drugs

Avg: 22%

$200
Average prescription price

Avg: $56

LOIS ALBURY MD

Internal Medicine

306

$21.5K

111
65 are 65+

14%
patients receiving schedule two controlled substances

Avg: 6%

13%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

36%
prescriptions for brand name drugs

Avg: 22%

$70
Average prescription price

Avg: $56

AMEE RATHOD M.D.

Internal Medicine

307

$74.8K

54
30 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

38%
prescriptions for brand name drugs

Avg: 22%

$244
Average prescription price

Avg: $56

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank